batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. No giving up on ROR1 for Oncternal 11 August 2023 iTeos joins Roche in delaying a TIGIT readout 8 August 2023 BioNTech enters the TROP2 space 7 August 2023 Cardiff Oncology doubles down on onvansertib 7 August 2023 Bristol axes two early Celgene projects 4 August 2023 Taiho takes front-line zipalertinib into phase 3 3 August 2023 Pfizer culls three phase 1 projects 1 August 2023 Immunotherapy disappoints in prostate cancer 27 July 2023 Load More